F021 Where Do We Stand? The Pathogenesis and Treatment of Melasma
DESCRIPTION
Melasma is a global disorder of major cosmetic significance. It negatively impacts the quality of life of patients. The pathogenesis of melasma is complex. Multiple recent studies document the interplay of genetics, inflammation, oxidative stress, abnormal vascular responses, senescent fibroblasts, and sensitivity to hormones in the pathogenesis of the disorder. Recent data suggest that it is a phenotype of photodamage. Multiple new therapies offer significant improvement. This forum will review the most recent global advances in pathogenesis and treatment of melasma. Therapies reviewed will include photoprotection, topical and oral agents, chemical peels, microneedling, PRP, lasers and emerging therapies.
LEARNING OBJECTIVES
Succinctly review new data on pathogenesis of melasma. Summarize new data on the pathogenesis of melasma.
Discuss conventional therapies including hydroquinone, & non-hydroquinone lightening agents, as well as new targets & new agents for skin lightening.
Review resurfacing procedures, including chemical peels, lasers & energy based devices, PRP, & microneedling. We will review the risk/benefit ratios of each procedure.
SCHEDULE
9:00 AM
Introduction - Melasma: The Turmoil Within
Pearl E. Grimes, MD, FAAD
9:15 AM
Unraveling the Cellular and Molecular Pathways Behind the Turmoil
Helio A. Miot, MD, PhD, IFAAD
9:30 AM
Beyond UV: Rethinking Photoprotection Strategies
Maria Ivonne Arellano-Mendoza, MD, IFAAD
9:45 AM
Topical Therapies: Enduring Agents and Emerging Frontiers
Heather Clare Woolery-Lloyd, MD, FAAD
10:00 AM
Oral Therapies: Treating the Turmoil Within
Seemal R. Desai, MD, FAAD
10:15 AM
Chemical Peels and Beyond: Optimizing Outcomes
Pearl E. Grimes, MD, FAAD
10:30 AM
Energy-Based Devices: Precision, Promise and Pitfalls
Arielle N.B. Kauvar, MD, FAAD
10:45 AM
Questions and Answers
DIRECTOR
Pearl E. Grimes, MD, FAAD
American Academy of Dermatology, American Society for Dermatologic Surgery, American Dermatological Association, Dermatology Foundation, Global Vitiligo Foundation, International Peeling Society, International Federation of Pigment Cell Societies, Skin of Color Society, Society for Investigative Dermatology, Women’s Dermatologic Society.
SPEAKERS
Maria Ivonne Arellano-Mendoza, MD, IFAAD
Seemal R. Desai, MD, FAAD
Arielle N.B. Kauvar, MD, FAAD
New York Laser & SkinCare, New York, NY; NYU Langone Health
Helio A. Miot, MD, PhD, IFAAD
Faculdade de Medicina de Botucatu - Unesp
DISCLOSURES
Maria Ivonne Arellano-Mendoza, MD, IFAAD
Bioderma – Speaker(Honoraria); Cantabria Labs – Speaker(Honoraria); Farmapiel – Speaker(Honoraria); Galderma Laboratories, LP – Advisory Board(Honoraria); Genove Dermatologics – Speaker(Honoraria); ISDIN – Advisory Board(Honoraria); ISIS Pharma – Speaker(Honoraria); NENUPHARM – Investigator(Honoraria); Pierre Fabre Dermo Cosmetique France – Advisory Board(Honoraria); Sanfer, S.L. – Speaker(Honoraria);
Seemal R. Desai, MD, FAAD
AbbVie – Consultant(Fees), Speaker(Fees); Apogee Therapeutics – Consultant(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Beiersdorf, Inc. – Consultant(Fees); Bristol-Myers Squibb – Consultant(Fees); Castle Biosciences – Consultant(Fees); Eli Lilly and Company – Consultant(Fees); Ferndale Laboratories, Inc. – Consultant(Honoraria); Foundation for Research & Education of Dermatology – Advisory Board(Fees); Galderma Laboratories, LP – Consultant(Fees), Speaker(Honoraria); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Gore Range Capital – Consultant(Stock Options), Stockholder(Stock Options); Illuminate Skin Care LLC – Founder(Other Financial Benefit); Incyte Corporation – Consultant(Fees), Investigator(Grants/Research Funding); International Society of Dermatology – Board of Directors(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Fees); Johnson and Johnson – Consultant(Fees); L'Oreal USA Inc. – Consultant(Fees); Leo Pharma Inc. – Consultant(Fees); Lyceum Health – Consultant(Fees); Medscape – Other(Fees); National Psoriasis Foundation – Other(No Compensation Received); Ortho Dermatologics – Consultant(Fees); PDH Holdings LLC – Other(No Compensation Received); Pfizer Inc. – Consultant(Fees), Speaker(Honoraria); Sanofi/Regeneron – Consultant(Fees); Scientis – Consultant(Fees); Sensus Healthcare – Consultant (1099 relationship)(Honoraria); Skin Science Advisors – Consultant(Fees); SkinMedica, Inc. – Investigator(Grants/Research Funding); UCB – Consultant(Fees); VYNE Therapeutics – Consultant(Fees);
Pearl E. Grimes, MD, FAAD
AbbVie – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Grants/Research Funding); Laseroptek USA – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant(Honoraria); Scientis – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Investigator(Grants/Research Funding); Versicolor Technologies – Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Honoraria);
Arielle N.B. Kauvar, MD, FAAD
Acclaro Medical – Advisory Board(Honoraria); Lumenis – Investigator(Grants/Research Funding); Sofwave – Investigator(Grants/Research Funding);
Helio A. Miot, MD, PhD, IFAAD
AbbVie – Investigator(Fees); Beiersdorf, Inc. – Speaker(Fees); E.M.S. Farmaceutica – Advisory Board(Fees); Galderma Brasil Ltda – Consultant (1099 relationship)(Fees); Johnson & Johnson Pharmaceutical Research & Development – Consultant (1099 relationship)(Fees); L'Oreal – Consultant (1099 relationship)(Fees); Lecieza – Consultant (1099 relationship)(Fees); Merz Aesthetics – Other(Fees); Pfizer Inc. – Speaker/Faculty Education(Fees); Pierre Fabre Dermatologie – Investigator(Fees); Sanofi Genzyme – Speaker(Fees); TheraSkin Farmacêutica – Investigator(Fees);